Satter Management

Latest statistics and disclosures from Alerce Investment Management's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are ANNX, AKBA, VRNA, AMWL, WHWK, and represent 100.00% of Alerce Investment Management's stock portfolio.
  • Reduced shares in these 1 stock: VRNA (-$5.5M).
  • Alerce Investment Management was a net seller of stock by $-5.5M.
  • Alerce Investment Management has $57M in assets under management (AUM), dropping by -8.86%.
  • Central Index Key (CIK): 0001844002

Tip: Access up to 7 years of quarterly data

Positions held by Satter Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Alerce Investment Management

Alerce Investment Management holds 5 positions in its portfolio as reported in the December 2024 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Annexon (ANNX) 66.9 $38M 7.4M 5.13
 View chart
Akebia Therapeutics (AKBA) 19.2 $11M 5.7M 1.90
 View chart
Verona Pharma Sponsored Ads (VRNA) 7.2 $4.1M -57% 88k 46.44
 View chart
American Well Corp Com Cl A New (AMWL) 6.7 $3.8M 524k 7.25
 View chart
Aadi Bioscience (WHWK) 0.0 $2.1k 659.00 3.15
 View chart

Past Filings by Alerce Investment Management

SEC 13F filings are viewable for Alerce Investment Management going back to 2020